Stay updated on Obinutuzumab in SLE: Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in SLE: Clinical Trial page.

Latest updates to the Obinutuzumab in SLE: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history updated: v3.3.2 was added and v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the general notice about government funding delays from the page.SummaryDifference0.4%

- Check42 days agoChange DetectedThe old and new screenshots show routine updates to the record history and Contacts/Locations sections; these are minor page maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now adds current-date markers and new sections for study status, design, and contacts/locations, replacing the older July 2025 reference. This expands core content with more organizational and contact information.SummaryDifference1%

- Check71 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference9%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Obinutuzumab in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in SLE: Clinical Trial page.